why choose us

First received: January 29, 2023

Clinical Trial: The Tolerability and Pharmacokinetics of HX301 Monolactate Capsules in Patients With Advanced Solid Tumors

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Advanced Solid Tumors

Study Type: Interventional


Official Title: A Phase I Clinical Trial of the Tolerability and Pharmacokinetics of HX301 Monolactate Capsules in Patients With Advanced Solid Tumors

Brief Summary: Open label, single- and multiple-dose administration, dose-exploratory clinical phase I study to evaluate the safety, tolerability and PK profile of HX301 monolactate capsules in patients with advanced malignant solid tumors and to preliminarily evaluate its antitumor efficacy.

Read more